News & Updates

The use of a phosphodiesterase type 5 (PDEV) inhibitor in patients with preheart failure (pre-HF) does not appear to produce improvements in glomerular filtration rate and urinary sodium/cGMP excretion as compared with placebo, as shown in a study.

Newborn screening (NBS) can facilitate the early detection of late-onset Pompe disease, leading to timely intervention, a recent study has found.

The treatment scope of oral anticoagulants (OACs) remains poor despite increasing treatment rates among high-risk atrial fibrillation (AF) patients, which is primarily credited to the expanding direct oral anticoagulant (DOAC) use, reports an Israel study.

A transseptal needle can be used to recanalize the complete long-segment occlusion of the superior vena cava (SVC) without needing to invest further vascular resources, a recent study has found.

Children with central venous thrombosis (CVT) and associated head or neck infections see good 3-month outcomes after treatment with therapeutic anticoagulants, according to a subgroup analysis of the EINSTEIN-Jr study.

Rivaroxaban was associated with a greater risk of major ischaemic or haemorrhagic events compared with apixaban in elderly patients with atrial fibrillation (AF) — suggesting that apixaban appears to be preferable over rivaroxaban when considering oral anticoagulant choice in these patients, according to a retrospective cohort study.